Good pay but poor management and bias issues - Recensione dipendente - Finance Organization presso BeOne

1,0
19 apr 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Good compensation compared to industry

Svantaggi

Management does not have a clue. They keep implementing processes and policies without checking for best practices. Lots of meetings and presentations focused but that is a waste in time. Company does not value hard work and long hours. The structure of the company is favored towards Asians and hiring Asians.

Esplora altre recensioni su BeOne

5,0
24 apr 2026
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

BeOne Medicines is building a strong reputation as a global oncology-focused company with a patient-centered approach. They’ve demonstrated the ability to advance innovative therapies across both hematologic malignancies and solid tumors, while also expanding their global footprint in clinical development. Their collaborative culture and emphasis on scientific rigor make them a compelling organization to work with and learn from.

Svantaggi

Fast timelines and global expansion may translate into heavy workload and urgency

5,0
22 apr 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

chance to make a bigger impact than at big pharma but not as risky as a small biotech or start up where the company can run out of funding, high pay, flexible hours

Svantaggi

longer work hours, off-hour calls with different regions depending on the role, experiences can vary by group

Vedi recensioni per: Utile|Valutazione|Data|Tutto